Synergistic anticancer effects of Chrysin and trastuzumab in HER2-Positive breast cancer cells
8.5
来源：
Nature
关键字：
ML brain science
发布时间：
2025-11-21 23:36
摘要：
Chrysin, a natural flavonoid, significantly enhances the efficacy of trastuzumab in HER2-positive breast cancer cells, as demonstrated by improved apoptosis rates and reduced HER2 expression. This study highlights the potential of combining natural compounds with targeted therapies to overcome resistance and improve treatment outcomes in oncology. The findings suggest that further investigation into the mechanisms and clinical applicability of this combination therapy is warranted.
原文：
查看原文
价值分投票
评分标准
新闻价值分采用0-10分制，综合考虑新闻的真实性、重要性、时效性、影响力等多个维度。
评分越高，表示该新闻的价值越大，越值得关注。
价值维度分析
domain_focus
1.0分+1.0分（符合肿瘤学领域）
business_impact
0.5分+市场拓展潜力
scientific_rigor
1.5分+具体实验数据支持
timeliness_innovation
1.5分+重大创新
investment_perspective
2.5分+早期研发阶段
market_value_relevance
1.0分+高发疾病相关性
team_institution_background
0.5分+知名机构背景
technical_barrier_competition
0.5分+一定技术壁垒
关键证据
Chrysin enhanced the anticancer effects of trastuzumab, achieving a combination index of 0.39.
Combination therapy significantly decreased HER2 expression and increased apoptosis rates.
Chrysin's ability to modulate angiogenesis-related factors supports its therapeutic potential.
真实性检查
否
AI评分总结
Chrysin, a natural flavonoid, significantly enhances the efficacy of trastuzumab in HER2-positive breast cancer cells, as demonstrated by improved apoptosis rates and reduced HER2 expression. This study highlights the potential of combining natural compounds with targeted therapies to overcome resistance and improve treatment outcomes in oncology. The findings suggest that further investigation into the mechanisms and clinical applicability of this combination therapy is warranted.